Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Zang

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Oncotarget|December 2, 2015
Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivoHongbiao Huang, Yuning Liao, Ningning Liu, et al.
Theranostics|January 6, 2022
Tubular epithelial cell-to-macrophage communication forms a negative feedback loop via extracellular vesicle transfer to promote renal inflammation and apoptosis in diabetic nephropathyWen-Juan Jiang, Chuan-Ting Xu, Chang-Lin Du, et al.
Oncotarget|September 7, 2014
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanismsXin Chen, Xianping Shi, Chong Zhao, et al.
Biochemical Pharmacology|July 7, 2016
Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapyChong Zhao, Xin Chen, Dan Zang, et al.
Oncotarget|January 14, 2017
Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinasesChong Zhao, Xin Chen, Changshan Yang, et al.
Scientific Reports|July 21, 2015
Performance of genetic risk factors in prediction of trichloroethylene induced hypersensitivity syndromeYufei Dai, Ying Chen, Hanlin Huang, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Oncotarget|December 2, 2015
Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivoHongbiao Huang, Yuning Liao, Ningning Liu, et al.
Theranostics|January 6, 2022
Tubular epithelial cell-to-macrophage communication forms a negative feedback loop via extracellular vesicle transfer to promote renal inflammation and apoptosis in diabetic nephropathyWen-Juan Jiang, Chuan-Ting Xu, Chang-Lin Du, et al.
Oncotarget|September 7, 2014
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanismsXin Chen, Xianping Shi, Chong Zhao, et al.
Biochemical Pharmacology|July 7, 2016
Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapyChong Zhao, Xin Chen, Dan Zang, et al.
Oncotarget|January 14, 2017
Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinasesChong Zhao, Xin Chen, Changshan Yang, et al.
Scientific Reports|July 21, 2015
Performance of genetic risk factors in prediction of trichloroethylene induced hypersensitivity syndromeYufei Dai, Ying Chen, Hanlin Huang, et al.
Pageof 13